Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (62)

2023

  1. Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review

    Cells, Vol. 12, Núm. 5

  2. Prognostic Usefulness of Basic Analytical Data in Chronic Obstructive Pulmonary Disease Exacerbation

    Open Respiratory Archives, Vol. 5, Núm. 4

  3. Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155

2022

  1. Association of rhinitis with asthma prevalence and severity

    Scientific Reports, Vol. 12, Núm. 1

  2. Correction to: Impact of anxiety and depression on the prognosis of copd exacerbations (BMC Pulmonary Medicine, (2022), 22, 1, (169), 10.1186/s12890-022-01934-y)

    BMC Pulmonary Medicine

  3. GCKIII (Germinal Center Kinase III) Kinases STK24 and STK25 (Serine/Threonine Kinase 24 and 25) Inhibit Cavernoma Development

    Stroke, Vol. 53, Núm. 3, pp. 976-986

  4. Lipodystrophy-associated progeroid syndromes

    Hormones, Vol. 21, Núm. 4, pp. 555-571

  5. Proteomic analysis of food allergens

    Food Proteomics: Technological Advances, Current Applications and Future Perspectives (Elsevier), pp. 225-300

  6. Risk Factors of Mortality in Hospitalized Patients With COVID-19 Applying a Machine Learning Algorithm

    Open Respiratory Archives, Vol. 4, Núm. 2

  7. The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids

    ERJ Open Research

2021

  1. Celia’s encephalopathy (Bscl2-gene-related): Current understanding

    Journal of Clinical Medicine, Vol. 10, Núm. 7

  2. Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort

    Clinical and Translational Allergy, Vol. 11, Núm. 1

  3. Distinctive cd26 expression on cd4 t-cell subsets

    Biomolecules, Vol. 11, Núm. 10

  4. Efficacy of mepolizumab in usual clinical practice and characteristics of responders: Mepolizumab in usual clinical practice

    Respiratory Medicine, Vol. 187

  5. Familial partial lipodystrophy syndromes

    Presse Medicale

  6. Igf1r as a potential pharmacological target in allergic asthma

    Biomedicines, Vol. 9, Núm. 8

  7. Immunology and immunotherapy in CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 435-453

  8. Short oligoalanine helical peptides for supramolecular nanopore assembly and protein cytosolic delivery

    RSC Chemical Biology, Vol. 2, Núm. 2, pp. 503-512

  9. Variability of blood eosinophil count and prognosis of COPD exacerbations

    Annals of Medicine, Vol. 53, Núm. 1, pp. 1152-1158

  10. Variable expressivity and allelic heterogeneity in type 2 familial partial lipodystrophy: The p.(thr528met) lmna variant

    Journal of Clinical Medicine, Vol. 10, Núm. 7